BACK TO GROUPNEWS Serafin Group has made a further investment in the health care sector by acquiring Gross GmbH, a regionally leading provider of medical aids. Following the successful acquisition of OTB and rehability in 2024, Serafin is strategically building its market presence and expanding its care proposition for patients, especially in southern Germany. The purchase agreement was signed on 1 April 2025 with the transaction closing on the same day.
Gross GmbH is one of the longest standing, family-owned companies within its sector in Ludwigsburg. Founded in 1856 by Ernst Gross, the Company developed over six generations into a renowned healthcare provider operating with 110 employees from six locations.
“For almost 170 years we have been providing our customers with expertise and first-class service. Securing the succession of our business was a crucial step for us. With Serafin and OTB, we found a partner who shares our values, appreciates tradition and offers a long-term perspective – which is exactly what we wished for the future of our family business,” said Martin Gross, Managing Director and owner of Gross GmbH for the last 44 years.
Gross GmbH will retain its reputable name and will operate as a subsidiary of OTB GmbH. Achieving continuity and stability for patients, customers, employees and partners is key for future success. The goal is to achieve long-term, profitable growth supported by process optimisation and digitalisation.
“Following the successful acquisition of OTB and rehability, we consider this the right time for our first strategic bolt-on. With Gross GmbH we have added a regionally strong company, which complements our care proposition in southern Germany and underscores our growth ambitions within the healthcare segment,” according to Dr Simon Brösamle, Operating Partner at Serafin Group.
The parties have agreed not to disclose the contractual details of the transaction.